购物车
全部删除
您的购物车当前为空
别名 贝汀维单抗, ZTS-00508841, ZTS00508841
Bedinvetmab (ZTS-00508841) 是一种犬源单克隆抗体 (mAb),靶向神经生长因子 (NGF)。Bedinvetmab 阻止 NGF 与其受体肌动蛋白受体激酶 A (trkA) 及 p75 神经营养素受体 (p75NTR) 的结合。Bedinvetmab 主要用于骨关节炎研究。
Bedinvetmab (ZTS-00508841) 是一种犬源单克隆抗体 (mAb),靶向神经生长因子 (NGF)。Bedinvetmab 阻止 NGF 与其受体肌动蛋白受体激酶 A (trkA) 及 p75 神经营养素受体 (p75NTR) 的结合。Bedinvetmab 主要用于骨关节炎研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | 现货 | |
| 5 mg | ¥ 5,860 | 现货 | |
| 10 mg | ¥ 7,890 | 现货 | |
| 25 mg | ¥ 11,700 | 现货 |
Bedinvetmab 相关产品
| 产品描述 | Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) engineered to target nerve growth factor (NGF). Bedinvetmab prevents NGF from binding its receptors, tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR). Bedinvetmab is primarily utilized in osteoarthritis research, where it is studied for its ability to manage pain in canine models. |
| 体内活性 | Bedinvetmab(0.5-1 mg/kg,皮下注射,每28天)能够有效减轻与犬骨关节炎相关的疼痛[1]。Bedinvetmab(1 mg/kg,皮下注射,每月;3倍和10倍剂量)与Carprofen联合给药,在正常实验室比格犬中显示出良好的耐受性[2]。 |
| 别名 | 贝汀维单抗, ZTS-00508841, ZTS00508841 |
| CAS No. | 2171034-69-6 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
评论内容